Programme Specifications Bachelor of Pharmaceutical ... · Department of Microbiology and...

Faculty of Pharmacy Programme Specifications Cairo University 2010

1

Programme Specifications

Bachelor of Pharmaceutical Sciences (Clinical Pharmacy)

(2010)

A. Administrative Information

1. Programme title: Bachelor Degree in Pharmaceutical Sciences (Clinical Pharmacy)

2. Programme type: Single

3. Award / degree: Bachelor Degree in Pharmaceutical Sciences (Clinical Pharmacy)

4. Department responsible:

a. Department of Pharmaceutics.

b. Department of Pharmacognosy.

c. Department of Pharmacology and Toxicology.

d. Department of Microbiology and Immunology.

e. Department of Organic Chemistry.

f. Department of Analytical Chemistry.

g. Department of Biochemistry.

h. Department of Pharmaceutical Chemistry.

i. Department of Clinical Pharmacy.

5. Coordinator: Prof. Dr. Manal Maher, Professor of Microbiology

6. External evaluator: Prof. Dr. Saeed Al-Feki, Professor of Organic Chemistry,

Faculty of Pharmacy, Zagazig University

7. Date of the most recent approval of programme specifications by the faculty council:

26/10/2010.

B. Professional Information

1. Programme aims:

The program aims to produce clinical pharmacists capable of providing specialist

pharmaceutical services in all clinical environments, thereby enhancing the quality

use of medicine. The programme fosters pharmacists who can attain a successful


2

career and provide skilled and ethical pharmaceutical care. This is achieved through

developing a programme with an appropriate mix of basic, pharmaceutical, medical,

social, behavioral management, health and environmental sciences. Graduates will be

able to take a leading role in the decision making process of drug and drug product

selection for individual patients, provide specialist drug information and education

programs to patients and health care professionals effectively monitor a patient's

therapy and critically evaluate clinical research.

This multidisciplinary programme is designed to prepare our pharmacy graduates to

have a powerful impact in the various fields of pharmacy including community

pharmacies, hospitals, pharmaceutical firms, pharmaceutical Industrial companies as

well as, academic and research institutes.

I. Attributes of the graduates:

The graduates of the Faculty of Pharmacy, Cairo University should demonstrate

outstanding skills as follows:

I.1. Be able to deal with and handle chemicals and natural products in a safe way.

I.2. Handle pharmaceutical products effectively according to pharmacy law and

legislations.

I.3. Formulate and dispense different pharmaceutical products.

I.4. Apply principles of quality control and quality assurance for pharmaceutical

products and natural products.

I.5. Analyze qualitatively and quantitatively raw materials, pharmaceutical products,

and biological samples

I.6. Perform according to Good Laboratory Practice (GLP), Good Pharmaceutical

Manufacturing Practice (GPMP) and current Good Manufacturing Practice

(cGMP) guidelines

I.7. Educate patients and community about proper and safe use of medications as

well as risks of abuse drugs, radiation and different xenobiotics.

I.8. Provide patients with information about the purpose and use of medications and

medical devices.

I.9. Provide patient care using different patient counseling techniques, therapeutic

plan and documentation.


3

I.10. Provide pharmaceutical care through understanding the role of the clinical

pharmacist in the society according to national and international needs

I.11. Demonstrate principles of understanding of etiology, pathophysiology and

management of diseases.

I.12. Work effectively with different health care professionals using evidence based

information

I.13. Promote health care knowledge to patients and other health care providers

I.14. Demonstrate capability in management of different drug, food, or chemical

induced toxicity.

I.15. Provide initial first aid measures

I.16. Plan, design and conduct research

I.17. Demonstrate good presentation, marketing and business administration skills

I.18. Develop numeracy, statistics skills

I.19. Develop information technology skills

I.20. Gather & analyze patient and medication information

I.21. Achieve a high level of pharmaceutical care by improving communication with

patients and health care professionals

I.22. Demonstrate problem solving and time management skills.

I.23. Demonstrate capability of decision-making through available information

I.24. Demonstrate ability of team working.

I.25. Apply legal, ethical, social, cultural, economics and professional codes.

I.26. Conform with principles of ethnicity, ethnocentrism, prejudice, race and

stereotype subcultures

I.27. Implement different professional skills throughout his professional career.

I.28. Upgrade his/her professional and scientific information by continuous learning.

2. Intended learning outcomes (ILOs) for programme

II. Knowledge and understanding:

The pharmacy graduate must demonstrate comprehensive knowledge and clear

understanding of the core information associated with the profession as follows:

II.1. Basic principles of physical, organic, inorganic and analytical chemistry.

II.2. Basic principles of mathematics, computer sciences, and biophysics.


4

II.3. Principles of pharmaceutical, pharmacognostical, medical, health and

environmental sciences as well as pharmacy practice.

II.4. Principles of social, behavioral and pharmacy management sciences.

II.5. Types of active and inactive ingredients used in the preparation of

pharmaceutical products as well as their physical and chemical properties.

II.6. Principles of biotechnology, radiations and radio-labeled products.

II.7. Different analytical procedures taking into account GLP guidelines and different

validation procedures.

II.8. Principles of isolation, purification, identification and standardization methods of

active substances from natural and synthetic origin.

II.9. Principles of synthesis and purification of active pharmaceutical ingredients

II.10. Basics of drug- receptor interaction using various techniques.

II.11. Pharmacodynamics of existing drugs to develop and synthesize new drugs.

II.12. Fundamentals of clinical applications of targeted therapies

II.13. Different types of pharmaceutical dosage forms

II.14. Properties and advantages of novel drug delivery systems.

II.15. Unit operation and unit processes; sampling, packaging, labeling and proper

storage of pharmaceutical compounds from different origins.

II.16. Basics of pharmacokinetics and biopharmaceutics principles.

II.17. Therapeutic drug monitoring, dose adjustment and bioequivalence studies.

II.18. Principles of hospital pharmacy including total parentral nutrition and drug

distribution system.

II.19. The concept of pharmaceutical care

II.20. Concept of clinical rounding

II.21. Sources and control of microbial contaminations, sanitation, disinfection, and

other public health issues.

II.22. Principles of sterilization and microbiological quality control of pharmaceutical

products.

II.23. Principles of physiology and pathophysiology.

II.24. Principles of genomics and molecular biology technique.

II.25. Biochemical pathways and their correlation with various diseases.

II.26. Basis of nutrition and diet therapy in various diseases

II.27. Etiology, signs and symptoms of different diseases.


5

II.28. Interpretation of different laboratory diagnostic results

II.29. Concept and types of supportive treatment.

II.30. Theories and principles of different diseases, therapeutic choices and patient care

for each pharmacotherapeutic specialization

II.31. Theories and principles of diseases, therapeutic choices and patient care for

special care populations (pediatrics and geriatrics).

II.32. Mechanism of action, therapeutic use, dosage of different pharmacological drug

classes, as well as, from natural origin.

II.33. Adverse drug reactions, contraindications and other properties of different

pharmacological drug classes including drugs natural sources.

II.34. Principles and mechanisms of drug-drug, drug-food and drug-disease

interactions.

II.35. Basis of clinical pharmacology, and rational drug use.

II.36. Principles of alternative and complementary therapy.

II.37. Toxicological characteristics of xenobiotics including origin and identification.

II.38. Toxicity symptoms and control measures.

II.39. Principles of first aid measures.

II.40. Basics of mathematics, statistical analysis and pharmaceutical calculations.

II.41. Principles of pharmaceutical business management.

II.42. Principles pharmacy administration.

II.43. Basis of drug sales, marketing and drug promotion.

II.44. Basics of drug documentation.

II.45. Pharmacy laws and ethics as well as governmental regulations.

II.46. Principles of ethnicity, ethnocentrism prejudice, race and stereotype subcultures.

III. Professional and practical skills

By successful completion of the programme, students should have the following skills:

III.1. Use properly pharmaceutical and medical terminology

III.2. Handle chemicals and natural products according to safety guidelines.

III.3. Dispose hazardous solvents in laboratories using safety measures.

III.4. Demonstrate skills in compounding and dispensing pharmaceutical preparations.

III.5. Extract and isolate active ingredients from different sources.


6

III.6. Synthesize preliminary chemical substances and active constituents of different

drug categories

III.7. Purify and identify the newly synthesized chemical compounds or drugs.

III.8. Detect impurities and adulterants in different pharmaceutical preparations and

assess their limits.

III.9. Estimate different active ingredients using various analytical tools and

techniques.

III.10. Select the appropriate medication, non-medication and/or radio-therapy for a

given disease based on its etiology, pathophysiology, severity, patient medical

history, possible interactions and age-related factors.

III.11. Evaluate the selected drug therapy based on the patient`s progress and

laboratory results.

III.12. Select appropriate nutritional approaches for the management of different

medical conditions

III.13. Establish a therapeutic relationship with the patient, collect adequate patient

history, and provide drug therapy information/education to patients.

III.14. Present the patient's condition in a structured form.

III.15. Perform the suitable laboratory tests to diagnose infectious and non-infectious

diseases.

III.16. Apply the appropriate techniques for qualitative and quantitative assessment of

microbial growth.

III.17. Assess the activity of different antimicrobial agents in controlling microbial

growth.

III.18. Be aware of different stages and techniques of bioprocesses.

III.19. Investigate toxicity profiles of different xenobiotics.

III.20. Test for poisons in biological samples.

III.21. Determine drug metabolites in biological samples.

III.22. Operate and maintain laboratory equipment safely and efficiently.

III.23. Maintain public awareness on social health hazards of drug abuse and misuse.

III.24. Identify different types of drug interactions.

III.25. Counsel the patients and other health care professions about the proper and safe

use of medicines from different sources and possible interactions with other

drugs or food.


7

III.26. Educate patients about the appropriate health measures they should maintain

during and after drug administration.

III.27. Advise health care professionals about safety and efficacy of pharmaceutical

products.

III.28. Assess patient compliance

III.29. Advise medical team about ethno-culture characteristics and ways of

communication with patients from different cultures.

III.30. Differentiate between different types of supportive treatment.

III.31. Perform research studies based on scientific background and rationale approach

with good interpretation and analysis of the obtained results.

III.32. Demonstrate ability in preparing drug reports.

III.33. Adopt suitable documentation.

IV. Intellectual skills

By successful completion of the programme, students should show the following skills:

IV.1. Use pharmaceutical knowledge in formulating safe and effective medicines

including new drug delivery systems.

IV.2. Implement GLP, GCP and GPMP guidelines in pharmacy practice.

IV.3. Select appropriate tools or analytical method for the assay and quality control of

raw materials and pharmaceutical products

IV.4. Select appropriate biological methods for the assay of different drug classes.

IV.5. Predict and prevent physical and/or chemical incompatibilities in IV admixture.

IV.6. Select suitable methods for isolation, identification and standardization of active

pharmaceutical substances.

IV.7. Select suitable methods for synthesis, purification and identification of active

pharmaceutical substances.

IV.8. Apply computer-aided facilities, biological databases and bio-informatics in drug

design.

IV.9. Utilize different tools to estimate the properties of biopharmaceuticals or natural

pharmaceutical products.

IV.10. Select different methods for infection control and improve public health.


8

IV.11. Apply pharmacological and pharmacotherapeutic principles in the proper

selection of drugs from different sources for the management of different

diseases.

IV.12. Recognize the application of radioactive agents in diagnosis and treatment of

different condition.

IV.13. Apply principles of pharmaceutical care to the patients according to their

medical conditions or their diseases.

IV.14. Design a pharmaceutical care plan.

IV.15. Adjust the dose of different medication based on patient condition or on the

nature of the drug itself and select appropriate dose regimen.

IV.16. Recognize of different types of supportive treatment.

IV.17. Recognize adverse drug reactions, interactions and contra-indications of

different pharmaceutical drug classes.

IV.18. Apply the pharmacoeconomic principles in maintaining drug effectiveness

with reducing the drug treatment cost.

IV.19. Interpret and report on results obtained from experimental studies.

IV.20. Interpret and categorize data obtained from clinical rounds

IV.21. Evaluate data from published literature using critical analysis.

IV.22. Apply evidence-based guidelines, involving sciences, technology and

professional principles required in pharmacy practice.

IV.23. Assess the different body indices and measures.

IV.24. Differentiate between compliance concordance and adherence.

IV.25. Select an appropriate supportive treatment option for different patients.

IV. General and transferable skills

By successful completion of the programme, students should have the following skills:

V.1. Communicate clearly by verbal means.

V.2. Write report on the interpreted results of his/her research projects.

V.3. Communicate with different ethno-groups of patients.

V.4. Search the literature from different sources including the library, internet ….etc

V.5. Evaluate the information obtained from different sources.

V.6. Share and participate effectively in team work.


9

V.7. Calculate and statistically analyze data.

V.8. Demonstrate good information technology skills.

V.9. Demonstrate self-learning skills.

V.10. Be coherent with pharmaceutical ethical, legal and safety guidelines.

V.11. Implement different skills required for sales, marketing and pharmacy

administration.

V.12. Work effectively in a creative way within pre-determined time frame.

V.13. Develop different writing and presentation skills.

V.14. Evaluate and make decision to deal with different problems.

3. Academic standards

a. External references selected to confirm the appropriateness of academic standards

NARS was adopted as external reference guiding the Faculty of Pharmacy – Cairo

University to create its own academic standards.

b. Comparison of provision to selected external references.

The academic standards and educational programme committee, of Faculty of

Pharmacy, Cairo University has performed a comparative study of NARS vs. its

programme ILOs, which was approved by both external and internal evaluators (Table

1).


10

Table (1): Comparison between NARS and Clinical Pharmacy Programme ILOs Matrix

NARS

Clinical Pharmacy Programme ILOs

Attributes of the Graduates

I.1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

1.1 X X

1.2 X

1.3 X X X

1.4 X X X X

1.5 X X X X X

1.6 X

1.7 X X X X

1.8 X X X X

1.9 X X

1.10 X X


11

NARS


Knowledge and Understanding

II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

II.2

4

II.2

5

II.2

6

2.1 X X X X

2.2 X X

2.3 X

2.4 X X

2.5 X X X

2.6 X X

2.7 X

2.8 X X

2.9 X X X

2.10 X X

2.11 X X X X


12

NARS


Knowledge and Understanding (cont.)

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

2.12 X X X X X

2.13 X X X

2.14 X

2.15 X

2.16 X X X

2.17 X

2.18 X

2.19 X X

2.20 X

2.21 X X


13

NARS


Professional and Practical skills

III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33

3.1 X

3.2 X X

3.3 X

3.4 X X X X X

3.5 X X X X X

3.6 X X X X

3.7 X X X

3.8 X

3.9 X X

3.10 X X X X X X

3.11 X

3.12 X X


14

NARS


Intellectual Skills

IV.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5

4.1 X

4.2 X

4.3 X X

4.4 X

4.5 X X

4.6 X

4.7 X

4.8 X

4.9 X X X X

4.10 X X

4.11 X

4.12 X

4.13 X X X

4.14 X X X X


15

NARS


General and Transferable Skills

V.1

V.2

V.3

V.4

V.5

V.6

V.7

V.8

V.9

V.1

0

V.1

1

V.1

2

V.1

3

V.1

4

5.1 X X X

5.2 X X

5.3 X

5.4 X X

5.5 X

5.6 X

5.7 X

5.8 X

5.9 X

5.10 X


16

Table (2) Programme – Course ILOs Matrix

Courses

Attributes of the Graduates I.

1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

PC 101 X X

PC 102 X X X X X X

MD 101 X X X X X X X

PG 101 X X X X X X X X

MD 102 X

MS 101 X X X

EN 101 X X

PC 203 X X X X X X

PC 205 X X X X


MD 203 X X

PT 201 X X X X X X X X X

PT 202 X X X X X X X X X X

HU 201 X X


17

Courses


I.1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

PC 304 X X X X X X

PC 306 X X X X X X

PG 303 X X X X X X X X X X X X X

MD 304 X

MD 305 X X

EN 302 X X X

HU 302 X X

PB 401 X X X X X

PG 404 X X X X X X X X X X

PC 407 X X X X X X X X

PM 401 X X X X

MD 406 X


PT 404 X X X X


18

Courses


I.1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

PC 509 X X X X X X X X X

PM 502 X X X

PT 505 X X X X X X X X X X X X X

PB 502 X X X X X X X X X X


MD 507 X X X

PT 506 X X X X X X X X


PT 607 X X X X X X X X

PT 608 X X X X X X X X X X X X X X X


PG 606 X X X X X X X X X X X

MD 608 X

MD 609 X X X X X X


19

Courses


I.1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

PO 701 X X X X X X X X X X

PP 701 X X X X X X X X

PP 702 X X X X X X X X X X X X

PP 703 X X X X X X X X X X X X X X X X

PT 704 X X X X X X X

MD 710 X X X X X X

PM 703 X X X

PM 704 X X

PO 802 X X X X X X X X X X X X

PP 805 X X X X X X X X X X X X X X X


PC 808 X X X X X X X X X X X

PB 803 X X X X X X X X X X X X X X X

PP 806 X X X X X X X X X

PO 803 X X X X X X

PTE 13 X X X X X X X X


20

Courses


I.1

I.2

I.3

I.4

I.5

I.6

I.7

I.8

I.9

I.10

I.11

I.12

I.13

I.14

I.15

I.16

I.17

I.18

I.19

I.20

I.21

I.22

I.23

I.24

I.25

I.26

I.27

I.28

PO 904 X X X X X X X X


PP 907 X X X X X X X X X X


PP 909 X X X X X X X X X X X X X X

PO 906 X X X X X X X X X

HU 903 X X X X

PME5 X X X PO 007 X X X X X X X X X X X X PP 010 X X X X X X X X X X X X X X X PP 011 X X X X X X X X X X X X X X X




PP 015 X X X X X X X X X X X

PCE11 X X X X

Summer training X X X X X X X X X X X X X X X X X X X X X X X X X

ICDL X X X


21

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PC 101 X X

PC 102 X X X X

MD 101 X X

PG 101 X X X X

MD 102

MS 101 X

EN 101 X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PC 101

PC 102

MD 101 X

PG 101 X X X

MD 102 X X

MS 101 X X

EN 101


22

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PC 203 X X X X

PC 205 X X X

PG 202 X X X X

MD 203 X

PT 201 X X X X

PT 202 X X

HU 201 X X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PC 203

PC 205 X

PG 202 X X X

MD 203

PT 201 X

PT 202 X

HU 201 X X


23

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PC 304 X X X X X

PC 306 X

PG 303 X X X X

MD 304 X

MD 305 X X X

EN 302 X X

HU 302 X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PC 304

PC 306

PG 303 X X X X X X

MD 304

MD 305 X

EN 302

HU 302 X X


24

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PB 401 X X X

PG 404 X X X X

PC 407 X X

PM 401 X

MD 406 X X

PT 403 X X X

PT 404 X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PB 401 X X

PG 404 X X X X

PC 407

PM 401 X X

MD 406 X X

PT 403 X

PT 404 X X X


25

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PC 509 X X X

PM 502 X X

PT 505 X X X X X

PB 502 X X

PG 505 X X X X X

MD 507 X X

PT 506 X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PC 509 X X

PM 502 X X

PT 505 X

PB 502 X X X

PG 505 X X X X

MD 507 X

PT 506 X X


26

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PC 610 X X X

PT 607 X X X

PT 608 X

PT 609 X X

PG 606 X X X X X

MD 608 X

MD 609 X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PC 610 X X

PT 607 X

PT 608 X X X X

PT 609 X X

PG 606

MD 608 X X

MD 609 X X


27

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PO 701 X X X X X X X

PP 701 X X

PP 702 X X X

PP 703 X X X

PT 704 X X X X

MD 710 X X

PM 703 X

PM 704 X X X X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6


PP 701 X X

PP 702 X X X X X X

PP 703 X X X

PT 704

MD 710

PM 703 X

PM 704 X X


28

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3


PP 805 X

PG 807 X X

PC 808 X X X X

PB 803 X X X X

PP 806

PO 803 X X X X

PTE13 X X X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6


PP 805 X X X X

PG 807 X X X X

PC 808 X X

PB 803 X X X X X

PP 806 X X

PO 803 X X

PTE13 X


29

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3

PO 904 X X X X


PP 907 X X

PP 908 X X X X X X X

PP 909 X X

PO 906 X X X X X X

HU 903 X

PCE11 X

PME5 X X X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PO 904 X X X X X

PO 905 X X X X X X X X X X

PP 907 X

PP 908 X X X X X X X X X X



HU 903 X

PCE11

PME5 X


30

Courses


II.1

II.2

II.3

II.4

II.5

II.6

II.7

II.8

II.9

II.1

0

II.1

1

II.1

2

II.1

3

II.1

4

II.1

5

II.1

6

II.1

7

II.1

8

II.1

9

II.2

0

II.2

1

II.2

2

II.2

3


PP 010

PP 011

PP 012

PP 013

PP 014 X PP 015

PE

Summer training X X X X X X X X X

IDCL X

Courses

II.2

4

II.2

5

II.2

6

II.2

7

II.2

8

II.2

9

II.3

0

II.3

1

II.3

2

II.3

3

II.3

4

II.3

5

II.3

6

II.3

7

II.3

8

II.3

9

II.4

0

II.4

1

II.4

2

II.4

3

II.4

4

II.4

5

II.4

6

PO 007 X X X X X X X X X X PP 010 X X X X X

PP 011 X X X X

PP 012 X X X X

PP 013 X X X X

PP 014 X X X X X

PP 015 X

PE

Summer training X X X X X X X X X X X X X X X X X

ICDL X X X


31

Courses


III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33

PC 101 X X X X X

PC 102 X X X X X

MD 101 X X X

PG 101 X X X X X X

MD 102 X X X

MS 101 X

EN 101 X X X

PC 203 X X X X X X

PC 205 X X

PG 202 X X X X X

MD 203 X X

PT 201 X X X X X

PT 202 X X

HU 201

PC 304 X X X X X


32

Courses


III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33

PC 306

PG 303 X X X X X X X X X X X X X X

MD 304 X

MD 305 X X

EN 302 X X X

HU 302 X

PB 401 X X X X

PG 404 X X X X X X

PC 407 X X X X X X

PM 401 X X X

MD 406 X X X X


PT 404 X X

PC 509 X X X X


33

Courses


III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33

PM 502 X X X X


PB 502 X X X X X

PG 505 X X X X X X

MD 507 X

PT 506 X X

PC 610 X X X X X


PT 608 X X X X X X X X X X X X X

PT 609 X X X X X X

PG 606 X X X X X X X

MD 608 X X X X

MD 609 X


PP 701 X X X X X X


34

Courses


III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33



PT 704 X X X X X X

MD 710 X X X X X X

PM 703 X X

PM 704 X X

PO 802 X X X X X X X X X X X X X

PP 805 X X X X X X X X X

PG 807 X X X X X X

PC 808 X X X X X X X

PB 803 X X X X X X X

PP 806 X X

PO 803 X X X

PTE13 X X X X X X

PO 904 X X X X



35

Courses


III.

1

III.

2

III.

3

III.

4

III.

5

III.

6

III.

7

III.

8

III.

9

III.

10

III.

11

III.

12

III.

13

III.

14

III.

15

III.

16

III.

17

III.

18

III.

19

III.

20

III.

21

III.

22

III.

23

III.

24

III.

25

III.

26

III.

27

III.

28

III.

29

III.

30

III.

31

III.

32

III.

33

PP 907 X X X


PP 909 X X X X

PO 906 X X X X X

HU 903 X X

PME5 X X




PP 012 X X X X X X X X PP 013 X X X X X X X X


PP 015 X X X

PE

Summer

training X X X X X X X X X X X X X X X X X X X X

ICDL X


36

Courses

Intellectual Skills IV

.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5

PC 101 X

PC 102 X X X X X

MD 101 X

PG 101 X X X X

MD 102 X

MS 101 X X

EN 101 X X

PC 203 X X X X X

PC 205 X

PG 202 X X X X X

MD 203 X

PT 201 X X X X

PT 202 X X

HU 201 X


37

Courses

Intellectual Skills

IV.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5

PC 304 X X X X X

PC 306 X X


MD 304 X

MD 305 X X

EN 302 X

HU 302 X X

PB 401 X

PG 404 X X X X X


PM 401 X

MD 406 X X

PT 403 X X X

PT 404 X


38

Courses


.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5

PC 509 X X

PM 502 X X

PT 505 X X X X X

PB 502 X X

PG 505 X X X X X

MD 507 X

PT 506 X

PC 610 X X X X

PT 607 X X X

PT 608 X X X X X

PT 609 X X X

PG 606 X X X X X X

MD 608 X

MD 609 X


39

Courses


.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5


PP 701 X X X X

PP 702 X X X

PP 703 X X X X

PT 704 X X

MD 710 X X

PM 703 X X X

PM 704 X X X X



PG 807 X X X X

PC 808 X X X X

PB 803 X X

PP 806 X


40

Courses


.1

IV.2

IV.3

IV.4

IV.5

IV.6

IV.7

IV.8

IV.9

IV.1

0

IV.1

1

IV.1

2

IV.1

3

IV.1

4

IV.1

5

IV.1

6

IV.1

7

IV.1

8

IV.1

9

IV.2

0

IV.2

1

IV.2

2

IV.2

3

IV.2

4

IV.2

5

PO 803 X X

PTE13 X X

PO 904 X X

PO 905 X X X X X X

PP 907 X X X X


PP 909 X X X X X

PO 906 X X X

HU 903

PME5 X X X X

PO 007 X X X X X X PP 010 X X X X X X PP 011 X X X X X X X PP 012 X X X X X X PP 013 X X X X X X PP 014 X X X X X X X PP 015 X X X X PCE11 X

Summer training X X X X X X X X X X

ICDL X X X


41

Courses


V.1 V.2 V.3 V.4 V.5 V.6 V.7 V.8 V.9 V.10 V.11 V.12 V.13 V.14


PC 102 X X X

MD 101 X X X X X X X X X X X

PG 101 X X X X X

MD 102 X X X X X X X X X

MS 101 X X X

EN 101 X X X X X

PC 203 X X X


PG 202 X X X X X

MD 203 X X



HU 201 X




MD 304 X X

MD 305 X X

EN 302 X X X


42

Courses General and Transferable Skills

V.1 V.2 V.3 V.4 V.5 V.6 V.7 V.8 V.9 V.10 V.11 V.12 V.13 V.14

HU 302 X X



PC 407 X X X X X X X X X X

PM 401 X X X X X X X X X

MD 406 X X X X X

PT 403 X X X X X X X X X X X X



PM 502 X X X X

PT 505 X X X X X X X X X X X



MD 507 X X X




PT 608 X X X X X X




MD 609 X X X


43

Courses


V.1 V.2 V.3 V.4 V.5 V.6 V.7 V.8 V.9 V.10 V.11 V.12 V.13 V.14

PO 701 X X X X X X




PT 704 X X X X X X X X X X X


PM 703 X X X X X X X X X

PM 704 X X X X X X X



PG 807 X X X X X X

PC 808 X X X X X X

PB 803 X X X X X X X X X X X


PO 803 X X X

PTE13 X X X X X X X X X X X

PO 904 X X X X

PO 905 X X X X X


PP 908 X X X X X X


44

Courses


V.1 V.2 V.3 V.4 V.5 V.6 V.7 V.8 V.9 V.10 V.11 V.12 V.13 V.14


PO 906 X X X

HU 903 X X

PME5 X

PO 007 X X X X X

PP 010 X X X X X X

PP 011 X X X X X X

PP 012 X X X X X X

PP 013 X X X X X X

PP 014 X X X X X X


PCE11 X X X X X X

Summer

training X X X X X X X X X X X X X X

ICDL X X X X X X X X X


45

Courses contributing to the programme

Table (3): Courses contribution to the programme and their distribution over the 10 semesters

Semester One

Course

code Course Title

No of

hours/week NARS Programme ILOs

Lect. Pract.

PC 101 Physical and

Inorganic Chemistry 2 1

1.1 I.1, I.2

2.1, 2.2 II.1, II.5,

3.1, 3.2, 3.8, 3.11 III.1, III.2, III.3, III.22,

III.31

4.13 IV.19

5.1, 5.2, 5.3,5.4, 5.8,

5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.7, V.12, V.13, V.14

PC 102 Pharmaceutical

Organic Chemistry-I 2 1

1.1, 1.3, 1.8, 1.10 I.1, I.6, I.22, I.23, I.24, I.28

2.1, 2.2, 2.4 II.1, II.5, II.8, II.9

3.1, 3.2, 3.4, 3.10 III.1, III.2, III.3, III.8,

III.26

4.3, 4.5, 4.6, 4.11 IV.3, IV.4, IV.7, IV.8,

IV.17

5.1, 5.5, 5.8 V.1, V.9, V.12

MD 101 Biophysics 1 1

1.1, 1.6, 1.8, 1.10 I.1, I.16, I.22, I.23, I.24,

I.27, I.28

2.1, 2.17 II.1, II.2, II.40

3.2, 3.8, 3.11 III.2, III.22, III.31

4.13 IV.19

5.1, 5.2, 5.3, 5.4, 5.5,

5.6, 5.8, 5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.7, V.8, V.9, V.12, V.13,

V.14

PG 101 Botany and

Medicinal Plants 2 1

1.1, 1.4, 1.6, 1.8,

1.10

I.1, I.7, I.8, I.16, I.23, I.24,

I.27, I.28

2.1, 2.2, 2.4, 2.7,

2.13

II.3, II.5, II.8, II.15, II.32,

II.33, II.34

3.2, 3.4, 3.9, 3.10 III.2, III.8, III.23, III.24,

III.25

4.5, 4.7, 4.11, 4.13 IV.6, IV.9, IV.17, IV.21

5.2, 5.3, 5.8, 5.9 V.4, V.5, V.6, V.12, V.13


46

Course

code Course Title

No of


Lect. Pract.

MD 102 Cell Biology 1 1

1.3 I.5

2.11, 2.12 II.24, II.28

3.1, 3.6 III.1, III.15, III.18

4.13 IV.19

5.1, 5.2, 5.3, 5.5, 5.8,

5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.9, V.12, V.13, V.14

MS 101 Mathematics and

Statistics 2 ---

1.6, 1.7, 1.10 I.16, I.18, I.27

2.1, 2.17, 2.18 II.2, II.40, II.41

3.11 III.31

4.10, 4.13 IV.15, IV.19

5.1, 5.4, 5.7 V.2, V.7, V.11

EN 101 English Language 2 ---

1.7, 1.8 I.17, I.21

2.1 II.3

3.1, 3.5, 3.12 III.1, III.14, III.32

4.13 IV.19, IV.21

5.1, 5.2, 5.9 V.1, V.2, V.4, V.5, V.13


47

- Semester Two

Course

code Course Title

No of

hours/week NARS

Programme ILOs

Lect. Pract.


Organic Chemistry-2 2 1

1.1, 1.3, 1.8, 1.10 I.1, I.6, I.22, I.23, I.24,

I.28

2.1, 2.2, 2.4 II.1, II.5, II.8, II.9

3.1, 3.2, 3.4, 3.7, 3.10 III.1, III.2, III.3, III.8,

III.19, III.26

4.3, 4.5, 4.6, 4.11 IV.3, IV.4, IV.7, IV.8,

IV.17

5.1, 5.5, 5.8 V.1, V.9, V.12

PC 205

Pharmaceutical

Analytical

Chemistry-1

2 1

1.1, 1.3 I.1, I.2, I.5, I.6

2.1, 2.3, 2.4, 2.17 II.1, II.7, II.8, II.40

3.2 III.2, III.3

4.2 IV.2

5.1, 5.2, 5.3, 5.4, 5.5 V.1, V.2, V.4, V.5, V.6,

V.7, V.9

PG 202 Pharmacognosy-1 2 1

1.1, 1.4, 1.6, 1.8, 1.10 I.1, I.7, I.8, I.16, I.23,

I.24, I.27, I.28

2.1, 2.2, 2.4, 2.13, 2.16 II.3, II.5, II.8, II.32, II.33,

II.34, II.38

3.2, 3.4, 3.9, 3.10 III.2, III.8, III.23, III.24,

III.25

4.5, 4.7, 4.11, 4.13 IV.6, IV.7, IV.9, IV.17,

I.21

5.2, 5.3, 5.8, 5.9 V.4, V.5, V.6, V.12,

V.13

MD 203 Histology 2 1

1.5 I.11, I.12

2.1 II.3

3.1, 3.5 III.1, III.10

4.14 IV.22

5.1 V.1, V.2

PT 201 Physical Pharmacy 2 1

1.1, 1.2, 1.6, 1.7, 1.8,

1.10

I.1, I.3, I.16, I.18, I.22,

I.23, I.24, I.27, I.28

2.1, 2.2, 2.6, 2.17 II.1, II.3, II.5, II.13, II.40

3.2, 3.3, 3.8, 3.11, 3.12 III.2, III.4, III.22, III.31,

III.33

4.1, 4.7, 4.13 IV.1, IV.9, IV.19, IV.21

5.1, 5.2, 5.3, 5.4, 5.5, V.1, V.2, V.5, V.6, V.7,


48

5.8, 5.9, 5.10 V.8, V.9, V.12, V.13,

V.14

PT 202 Pharmacy

Orientation 2 -

1.1, 1.2, 1.6, 1.8, 1.9,

1.10

I.1, I.2, I.3, I.16, I.22,

I.23, I.24, I.25, I.27, I.28

2.1, 2.20 II.3, II.4, II.44

3.1, 3.12 III.1, III.33

4.1, 4.13 IV.1, IV.21

5.1, 5.2, 5.3, 5.4, 5.5,

5.8, 5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.8, V.9, V.12, V.13,

V.14

HU 201 Human Rights 2 -

1.9 I.25, I.26

2.21 II.45, II.46

----------- ----------

4.14 IV.22

5.6 V.10


49

- Semester Three

Course

code Course Title

No of


Lect. Pract.

PC 304 Pharmaceutical Organic

Chemistry-3 2 1

1.1, 1.3, 1.8, 1.10 I.1, I.6, I.22, I.23, I.24, I.28

2.1, 2.2, 2.4, 2.5 II.1, II.5, II.8, II.9, II.10

3.1, 3.2, 3.4 III.1, III.2, III.3, III.6, III.7

4.3, 4.5, 4.6, 4.11 IV.3, IV.4, IV.7, IV.8, IV.17

5.1, 5.2, 5.4, 5.7.

5.8 V.1, V.3, V.5, V.7, V.8, V.11, V.12


Analytical Chemistry-2 2 1

1.3, 1.8, 1.10 I.5, I.6, I.22, I.23,

I.24, I.28

2.3 II.7

------- ------

4.3, 4.13 IV.3, IV.19

5.1, 5.3, 5.4, 5.6,

5.8, 5.10

V.1, V.6, V.7, V.8,

V.10, V.12, V.14

PG 303 Pharmacognosy-2 2 1

1.1, 1.3, 1.4, 1.5,

1.6, 1.8, 1.10

I.1, I.4, I.5, I.7, I.8,

I.12, I.13, I.16, I.22,

I.23, I.24, I.27, I.28

2.1, 2.2, 2.4, 2.7,

2.13, 2.14, 2.16

II.3, II.5, II.8, II.15,

II.32, II.33, II.34,

II.36, II.37, II.38

3.1, 3.2, 3.3, 3.4,

3.5, 3.7, 3.8, 3.9,

3.10, 3.11, 3.12

III.1, III.2, III.4,


III.22, III.23, III.24,

III.25, III.27, III.31,

III.32, III.33

4.1, 4.3, 4.5, 4.7,

4.8, 4.9, 4.10, 4.11,

4.13

IV.1, IV.3, IV.6,

IV.9, IV.10, IV.11,

IV.15, IV.17, IV.19,

IV.21

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.8, V.9, V.12,

V.13, V.14

MD 304 Anatomy 1 1 1.5 I.11

2.1 II.2


50

3.1 III.1

4.14 IV.22

5.1 V.1, V.2

MD 305 Physiology 3 1

1.5 I.11, I.12

2.1, 2.9, 2.11, 2.12 II.3, II.18, II.23,

II.27

3.1, 3.5 III.1, III.10

4.14 IV.22, IV.23

5.1 V.1, V.2

EN 302 Medical Terminology 3 -

1.5, 1.7 I.12, I.13, I.17

2.1, 2.11 II.3, II.23

3.1, 3.5, 3.12 III.1, III.14, III.32

4.13 IV.21

5.1, 5.2 V.1, V.2, V.5

HU 302 Psychology 2 -

1.8, 1.10 I.21, I.27

2.1, 2.12, 2.19 II.4, II.29, II.43

3.5 III.13

4.9, 4.14 IV.13, IV.22

5.1, 5.7 V.1, V.11


51

- Semester Four

Course

Code Course Title

No of


Lect. Pract.

PB 401 Biochemistry-1 2 1

1.1, 1.3, 1.7, 1.8 I.1, I.5, I.17, I.19,

I.24

2.1, 2.3, 2.11, 2.12 II.1, II.3, II.7, II.24,

II.27

3.1, 3.2, 3.8 III.1, III.2, III.3,

III.22

4.13 IV.19

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.12, V.13

PG 404 Phytochemisty-1 2 1

1.1, 1.3, 1.4, 1.8,

1.9, 1.10

I.1, I.4, I.5, I.6, I.7,

I.8, I.23, 1.24, 1.27,

1.28

2.1, 2.2, 2.3, 2.4,

2.13, 2.15

II.3, II.5, II.7, II.8,

II.32, II.33, II.34,

II.36

3.2, 3.4, 3.10, 3.11 III.2, III.5, III.8,

III.9, III.25, III.31

4.3, 4.5, 4.7, 4.13 IV.3, IV.6, IV.9,

IV.19, IV.21

5.1, 5.2, 5.3, 5.5,

5.9, 5.10

V.1, V.4, V.5, V.6,

V.9, V.13, V.14

PC 407 Instrumental Analysis 1 1

1.3, 1.8, 1.10 I.4, I.5, I.6, I.22,

I.23, I.24, I.27, I.28

2.1, 2.3 II.1, II.7

3.4, 3.8, 3.11, 3.12 III.7, III.8, III.9,


4.3, 4.5, 4.7, 4.13 IV.3, IV.4, IV.6,

IV.7, IV.9, IV.19,

IV.21

5.1, 5.3, 5.4, 5.5,

5.6, 5.8, 5.9, 5.10

V.1, V.2, V.6, V.7,

V.8, V.9, V.10,V.12,

V.13, V.14

PM 401 General Microbiology

and Immunology 3 1

1.3, 1.5 I.4, I.5, I.6, I.11

2.10, 2.11, 2.12 II.21, II.24, II.28

3.6, 3.11 III.15, III.16, III.31

4.13 IV.19

5.1, 5.2, 5.3, 5.5, V.1, V.2, V.4, V.5,


52

5.8, 5.9, 5.10 V.6, V.9, V.12,

V.13, V.14

MD 406 Parasitology 1 1

1.5 I.11

2.1, 2.10, 2.12 II.3, II.21, II.27,

II.28

3.1, 3.5, 3.6, 3.11 III.1, III.10, III.15,

III.31

4.8, 4.13 IV.10, IV.19

5.1, 5.2, 5.3 V.1, V.2, V.4, V.5,

V.6

PT 403 Pharmaceutical Dosage

Forms-1 2 1

1.1, 1.2, 1.3, 1.8,

1.9, 1.10

I.1, I.2, I.3, I.5, I.22,

I.23, I.24, I.25, I.27,

I.28

2.1, 2.2, 2.6, 2.17 II.3, II.5, II.13, II.40

3.1, 3.2, 3.3, 3.7,

3.11, 3.12


III.21, III.31, III.32,

III.33

4.1, 4.13 IV.1, IV.19, IV.21

5.1, 5.2, 5.3, 5.4,

5.4, 5.5, 5.6, 5.8,

5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.10, V.12, V.13,

V.14

PT 404 Pharmacy Legislation 1 -

1.1, 1.9, 1.10 I.2, 1.25, I.27, I.28

2.1, 2.20, 2.21 II.4, II.44, II.45,

II.46

3.12 III.32, III.33

4.14 IV.22

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.8, V.9, V.12,

V.13, V.14


53

- Semester Five

Course

Code Course Title

No of


Lect. Pract.

PC 509 Medicinal Chemistry-1 2 1

1.1, 1.4,1.6, 1.8,

1.10

I.1, I.2, I.8, I.16,

I.22, I.23, I.24, I.27,

I.28

2.4, 2.5, 2.13 II.8, II.9, II.11, II.32,

II.33

3.2, 3.4 III.2, III.3, III.6,

III.8

4.5, 4.13 IV.7, IV.19

5.1, 5.2, 5.3, 5.5,

5.8,5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.9, V.12,

V.13, V.14

PM 502 Clinical Microbiology 2 1

1.3, 1.5 I.5, I.11, I.13

2.1, 2.11, 2.12 II.3, II.23, II.27,

II.28

3.1, 3.5, 3.6, 3.11 III.1, III.10, III.15,

III.31

4.8, 4.13 IV.10, IV.19

5.1, 5.3, 5.10 V.1, V.2, V.6, V.14

PT 505 Pharmaceutical Dosage

Forms-2 2 1

1.1, 1.2, 1.3, 1.6,

1.7, 1.8, 1.9, 1.10

I.1, I.2, I.3,I.4, I.6,

I.16, I.18, I.22, I.23,

I.24, I.25, I.27, I.28

2.1, 2.2, 2.6, 2.10,

2.17

II.3, II.5, II.13, II.14,

II.22, II.40

3.1,3.2, 3.3, 3.8,

3.11,3.12


II.22, III.31, III.32,

III.33

4.1, 4.2, 4.3, 4.10,

4.13

IV.1, IV.2, IV.5,

IV.15, IV.19

5.1, 5.2, 5.3, 5.4,

5.5, 5.6, 5.8, 5.9,

5.10

V.1, V.2, V.5, V.6,

V.7, V.8, V.9, V.10,

V.12, V.13, V.14

PB 502 Biochemistry-2 2 1

1.1, 1.3, 1.5,

1.6,1.7, 1.8, 1.10

I.1, I.5, I.11, I.16,

I.17, I.19, I.22, I.23,

I.24, I.28

2.1, 2.3, 2.11, 2.12 II.3, II.7, II.25, II.27,

II.28

3.1, 3.2, 3.6, 3.8 III.1, III.2, III.3,


54

III.15, III.22

4.13, 4.14 IV.19, IV.23

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.12, V.13

PG 505 Phytochemistry-2 2 1

1.1, 1.3, 1.4, 1.8,

1.10

I.1, I.4, I.5, I.6, I.7,

I.8, I.23, I.24, I.27,

I.28

2.1, 2.2, 2.3, 2.4,

2.13, 2.15

II.3, II.5, II.7, II.8,

II.32, II.33, II.34,

II.36

3.2, 3.4, 3.10, 3.11 III.2, III.5, III.8,


4.3, 4.5, 4.6, 4.13 IV.3, IV.6, IV.9,

IV.19, IV.21

5.1, 5.2, 5.3, 5.5,

5.9, 5.10

V.1, V.4, V.5, V.6,

V.9, V.13, V.14

MD 507 Pathophysiology 2 0

1.5, 1.10 I.11, I.12, I.13, I.27,

I.28

2.11, 2.12 II.23, II.27, II.30

3.1, 3.5 III.1, III.10

4.8, 4.9 IV.10, IV.13

5.1, 5.2, 5.3, 5.5 V.2, V.4, V.6, V.9

PT 506 Pharmacy

Administration 2 0

1.6, 1.7, 1.8, 1.10 I.16, I.17, I.18, I.22,

I.23, I.24, I.27, I.28

2.1, 2.18, 2.19 II.4, II.41, II.42

3.11, 3.12 III.31, III.33

4.13 IV.21

5.1, 5.2, 5.3, 5.4,

5.5, 5.6, 5.7, 5.8,

5.9, 5.10

V.1, V.2, V.5, V.6,

V.7, V.8, V.9, V.10,

V.11, V.12, V.13,

V.14


55

- Semester Six

Course

Code Course Title

No of


Lect. Pract.

PC 610 Medicinal Chemistry-2 2 1

1.1, 1.4, 1.6, 1.8,

1.10

I.1, I.2, I.8, I.16,

I.22, I.23, I.24, I.27,

I.28

2.4, 2.5, 2.13 II.8, II.9, II.11, II.32,

II.33

3.2, 3.4 III.2, III.3, III.6,

III.7, III.9

4.3, 4.5, 4.5, 4.13 IV.3, IV.6, IV.7,

IV.19

5.1,5.2, 5.3, 5.5,

5.8, 5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.9, V.12,

V.13, V.14

PT 607 Pharmaceutical Technology 2 1

1.1, 1.3, 1.6, 1.8,

1.9, 1.10

I.1, I.2, I.6, I.16,

I.24, I.25, I.27, I.28

2.1, 2.3, 2.7, 2.20 II.3, II.7, II.15, II.44

3.1, 3.2, 3.8, 3.10,

3.11, 3.12


III.22, III.31, III.32,

III.33

4.2, 4.5, 4.13 IV.2, IV.6, IV.19

5.1, 5.2, 5.3, 5.4,

5.5, 5.6, 5.8, 5.9,

5.10

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.10, V.12, V.13,

V.14

PT 608 Community Pharmacy

Practice 2 1

1.1, 1.2, 1.4, 1.5,

1.8, 1.9, 1.10

I.2, I.3, I.7, I.8, I.9,

I.11, I.12, I.13, I.21,

I.22, I.23, I.24, I.25,

I.27, I.28

2.1, 2.12, 2.13 II.3, II.27, II.29,

II.30, II.32

3.1, 3.3, 3.5,3.9,

3.10, 3.12


III.11, III.12, III.13,

III.14, III.23, III.24,

III.25, III.26, III.27,

III.33

4.9, 4.10, 4.11, 4.14 IV.11, IV.15, IV.17,

IV.22, IV.25

5.1, 5.3, 5.6, 5.8,

5.9, 5.10

V.1, V.6, V.10,

V.12, V.13, V.14


56

PT 609 Biopharmaceutics and

Pharmacokinetics 2 1

1.1, 1.3, 1.6, 1.7,

1.8, 1.9, 1.10

I.2, I.5, I.16, I.18,

I.22, I.23, I.24, I.25,

I.27, I.28

2.1, 2.8, 2.17, 2.21 II.3, II.16, II.40,

II.45

3.1, 3.4, 3.8, 3.11,

3.12



4.3, 4.7, 4.13 IV.3, IV.9, IV.19

5.1,5.2, 5.3, 5.4,

5.5, 5.6, 5.8,5.9,

5.10

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.10, V.12, V.13,

V.14

PG 606 Quality Control of

Herbal Drugs 2 1

1.1, 1.3, 1.4, 1.6,

1.8, 1.10

I.1, I.2, I.4, I.5, I.6,

I.7, I.16, I.23, I.27,

I.28

2.1, 2.2, 2.3, 2.4,

2.7

II.3, II.5, II.7, II.8,

II.15

3.2, 3.4, 3.8,

3.9,3.11, 3.12


III.22, III.23, III.31,

III.32

4.2, 4.3, 4.5,4.7,

4.13

IV.2, IV.3, IV.6,

IV.9, IV.19, IV.21

5.1, 5.2, 5.3, 5.4,

5.5, 5.9

V.1, V.2, V.4, V.5,

V.6, V.8, V.9, V.13

MD 608 Pathology 2 1

1.5 1.11

2.11, 2.12 II.23, II.27, II.28

3.1, 3.5, 3.6 III.1, III.10, III.11,

III.15

4.13 IV.19

5.1, 5.2, 5.2, 5.5,

5.8, 5.10

V.1, V.2, V.4, V.5,

V.9, V.12, V.14

MD 609 Traumas ad First Aid 2 0

1.5, 1.8, 1.9, 1.10 1.12, 1.14, 1.15,

1.22, 1.25, 1.27

2.1, 2.16 II.3, II.38, II.39

3.5 III.13

4.9 IV.13

5.3, 5.8, 5.10 V.6, V.12, V.14


57

- Semester Seven

Course

Code Course Title

No of


Lect. Pract.

PO 701 Pharmacology1 2 1

1.4, 1.5, 1.6, 1.8,

1.10

I.7, I.8, I.9, I.11, I.12,

I.13, I.16, I.22, I.23, I.27

2.1, 2.5, 2.6, 2.8,

2.11, 2.12, 2.12,

2.13, 2.14

II.3, II.10, II.11, II.12,

II.14, II.16, II.17, II.25,

II.27, II.30, II.32, II.33,

II.34, II.35

3.1, 3.4, 3.5, 3.8,

3.9, 3.10, 3.11, 3.12

III.1, III.7, III.10, III.13,

III.22, III.23, III.24,

III.25, III.26, III.27,

III.31, III.32.

4.5, 4.9, 4.10, 4.11,

4.13, 4.14

IV.6, IV.7, IV.11, IV.15,

IV.17, IV.19, IV.25

5.1, 5.3, 5.4, 5.8,

5.10

V.1, V.2, V.6, V.7, V.12,

V.14

PP 701 Radiopharmaceuticals 1 -

1.1, 1.2, 1.6, 1.8,

1.10

I.1, I.2, I.3, I.16, I.22,

I.23, I.27, I.28

2.1, 2.2, 2.17, 2.21 II.3, II.6, II.40, II.45

3.1, 3.2, 3.11, 3.12 III.1, III.2, III.3, III.31,

III.32, III.33

4.1, 4.2,4.9, 4.13 IV.1, IV.2, IV.12, IV.19

5.1, 5.2, 5.3, 5.4,

5.5,5.6, 5.8, 5.9,

5.10

V.1, V.2, V.4, V.5, V.6,

V.7, V.8, V.9, V.10,

V.12, V.13, V.14

PP 702 Clinical Pharmacy-1 2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.9, I.10, I.12, I.18, I.20,

I.21, I.22, I.23, I.24, I.25,

I.27, I.28

2.1, 2.9, 2.12, 2.13,

2.17, 2.20

II.3, II.19, II.20, II.28,

II.31, II.33, II.34, II.40,

II.44

3.1, 3.5, 3.9, 3.10,

3.12



4.9, 4.11, 4.14 IV.13, IV.17, IV.24

5.1, 5.2, 5.3, 5.6,

5.8, 5.9, 5.10

V.1, V.4, V.6, V.7, V.10,

V.12, V.13, V.14

PP 703 Hospital Pharmacy 2 1

1.1, 1.2, 1.4,1.5,

1.7, 1.8, 1.9, 1.10

I.1, I.2, I.3, I.7, I.8, I.9,

I.12, I.18, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28

2.1, 2.8, 2.9, 2.11, II.3, II.17, II.18, II.26,


58

2.14, 2.17 II.35, II.40

3.1, 3.2, 3.3, 3.5,

3.10, 3.12


III.12, III.13, III.25, III.33

4.4, 4.13, 4.14 IV.5, IV.20, IV.22, IV.23

5.1, 5.3, 5.4, 5.6,

5.8, 5.9, 5.10

V.1, V.3, V.6, V.7, V.10,

V.12, V.13, V.14

PT 704 Controlled Drug

Delivery Systems 2 -

1.1, 1.2, 1.6, 1.8,

1.10

I.1, I.2, I.3, I.16, I.23,

I.27, I.28

2.1, 2.2, 2.6 II.3, II.5, II.13, II.14

3.1, 3.2, 3.11, 3.12 III.1, III.2, III.3, III.31,

III.32, III.33

4.1, 4.13 IV.1, IV.19

5.1, 5.2, 5.3, 5.4,

5.5, 5.6, 5.8, 5.9,

5.10

V.1, V.2, V.4, V.5, V.6,

V.7, V.9, V.10, V.12,

V.13, V.14

MD 710 Public Health and

Preventive Medicine 2 -

1.4, 1.5 I.7, I.8, I.9, I.11, I.12, I.13

2.1, 2.10 II.3, II.21

3.5, 3.9, 3.10, 3.11 III.10, III.11, III.23,


4.8, 4.13 IV.10, IV.19

5.1, 5.2, 5.5, 5.8,

5.10

V.1, V.2, V.4, V.5, V.9,

V.12, V.14

PM 703 Pharmaceutical

Biotechnology 2 1

1.6, 1.7 I.16, I.19

2.2, 2.11 II.6, II.24

3.6, 3.11 III.16, III.31

4.6, 4.13, 4.14 IV.8, IV.21, IV.22

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9, 5.10

V.2, V.4, V.5, V.6, V.8,

V.9, V.12, V.13, V.14

PM 704 Pharmaceutical

Microbiology 2 1

1.3 I.4, I.6

2.1, 2.3, 2.10, 2.13 II.3, II.7, II.21, II.22,

II.32, II.33

3.6 III.16, III.17

4.8, 4.9, 4.10 IV.10, IV.11, IV.13,

IV.15

5.1, 5.2, 5.3, 5.5,

5.8, 5.10

V.1, V.4, V.5, V.6, V.9,

V.12, V.14


59

- Semester Eight

Course

Code Course Title

No of


Lect. Pract.

PO 802 Pharmacology-2 2 1

1.4, 1.5, 1.7, 1.8,

1.10

I.7, I.8, I.9, I.11, I.12, I.13,

I.17, I.22, I.23, I.24, I.27,

I.28

2.1, 2.5, 2.8, 2.11,

2.11, 2.12, 2.13,

2.14, 2.17

II.3, II.10, II.11, II.12,

II.16, II.17, II.23, II.25,

II.27, II.28, II.30, II.32,

II.33, II.34, II.35, II.40

3.1, 3.4, 3.5, 3.9,

3.10, 3.11


III.13, III.14, III.23, III.24,

III.25, III.26, III.27, III.31,

III.32

4.5, 4.9, 4.10, 4.11,

4.13, 4.14

IV. 6, IV.7, IV.11, IV.12,

IV.15, IV.17, IV.19, IV21,

IV.25

5.1, 5.2, 5.3,5.5,

5.8, 5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.9, V.12, V.13, V.14

PP 805 Clinical

Pharmacy-2 2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11, I.12,

I.13, I.20, I.21, I.22, I.23,

I.24, I.25, I.27, I.28

2.1, 2.12, 2.13 II.3, II.27, II.28, II.30, II.32

3.1, 3.5, 3.9, 3.10,

3.12


III.13, III.24, III.25, III.26,

III.33

4.9, 4.10, 4.11,

4.13, 4.14

IV.11, IV.13, IV.14, IV.15,

IV.17, IV.20, IV.22, IV.25

5.1, 5.3, 5.5, 5.6,

5.8, 5.9, 5.10

V.1, V.6, V.9, V.10, V.12,

V.13, V.14

PG 807 Phytotherapy 2 1

1.4, 1.5, 1.7, 1.10 I.7, I.8, I.9, I.12, I.13, I.22,

I.23, I.24, I.27, I.28

2.1, 2.5, 2.12, 2.13 II.3, II.10, II.30, II.32,

II.33, II.34

3.5, 3.8, 3.9, 3.10, III.10, III.12, III.23, III.25,

III.26, III.27

4.9, 4.10, 4.11 IV.11, IV.14, IV.15, IV.17

5.1, 5.2, 5.3, 5.5,

5.9

V.2, V.3, V.4, V.6, V.9,

V.13

PC 808 Pharmaceuticals 2 1 1.1, 1.3, 1.8, 1.9,

1.10

I.1, I.2, I.4, I.5, I.6, I.22,

I.23, I.24, I.25, I.27, I.28


60

Analysis &

Quality Control 2.2, 2.3, 2.6, 2.7,

2.20, 2.21

II.5, II.7, II.13, II.15, II.44,

II.45

3.2, 3.4, 3.8, 3.12 III.2, III.3, III.8, III.9,


4.2, 4.3, 4.13, 4.14 IV.2, IV.3, IV.21, IV.22

5.1, 5.3, 5.5, 5.6,

5.8, 5.10

V.2, V.6, V.9, V.10, V.12,

V.14

PB 803 Clinical

Biochemistry 2 1

1.1, 1.3, 1.5, 1.6,

1.7, 1.8, 1.10

I.1, I.5, I.11, I.12, I.13, I.16,

I.17, I.19, I.20, I.21, I.22,

II.23, I.24, I.27, I.28

2.1, 2.2, 2.3, 2.11,

2.12

II.3, II.6, II.7, II.23, II.24,

II.25, II.27, II.28, II.30

3.1, 3.2, 3.5, 3.6,

3.8



4.13, 4.14 IV.19, IV.23

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9, 5.10

V.1, V.2, V.4, V.5, V.6,

V.7, V.8, V.9, V.12, V.13,

V.14

PP 806 Drug Marketing 1 -

1.5, 1.7, 1.8, 1.9,

1.10

I.12, I.13, I.17, I.22, I.23,

I.24, I.25, I.27, I.28

2.19 II.42, II.43

3.10, 3.12 III.27, III.33

4.12 IV.18

5.1, 5.2, 5.3, 5.6,

5.7, 5.8, 5.9, 5.10

V.1, V.5, V.6, V.10, V.11,

V.12, V.13, V.14

PO 803 Drug Interactions 2 -

1.4, 1.5, 1.8, 1.10 I.7, I.12, I.13, I.22, I.27,

I.28

2.1, 2.5, 2.8, 2.11,

2.13

II.3, II.10, II.17, II.23,

II.33, II.34

3.5, 3.9, 3.10 III.10, III.24, III.25

4.4, 4.11 IV.5, I.17

5.3, 5.5, 5.10 V.6, V.9, V.14

PTE13 Cosmetic

Preparations 2 -

1.1, 1.2, 1.6, 1.8,

1.9, 1.10

I.1, I.2, I.3, I.16, I.24, I.25,

I.27, I.28

2.1, 2.2, 2.6, 2.21 II.3, II.5, II.13, II.45

3.1, 3.2, 3.11, 3.12 III.1, III.2, III.3, III.31,

III.33

4.1, 4.3 IV.1, IV.3

5.1, 5.2, 5.3, 5.4,

5.5, 5.6, 5.8, 5.9,

5.10

V.1, V.2, V.4, V.5, V.6,

V.8, V.9, V.10, V.12, V.13,

V.14


61

- Semester Nine

Course

Code Course Title

No of


Lect. Pract.

PO 904 Toxicology and

Forensic Chemistry 2 1

1.4, 1.5, 1.8, 1.10 I.7, I.12, I.13, I.14,

I.22, I.23, I.24, I.27

2.1, 2.2, 2.5, 2.11,

2.12, 2.13, 2.16

II.3, II.6, II.10, II.23,

II.25, II.28, II.33,

II.37, II.38

3.7, 3.9 III.19, III.20, III.21,

III.24

4.9, 4.11 IV.12, IV.17

5.2, 5.8, 5.10 V.4, V.5, V.12, V.14

PO 905 Therapeutics-1 2 1

1.4, 1.5, 1.7, 1.8,

1.10

I.7, I.8, I.9, I.11,

I.12, I.13, I.20, I.22,

I.23, I.24, I.27, I.28

2.1, 2.5, 2.6, 2.8,

2.9, 2.11, 2.12,

2.13, 2.14

II.3, II.10, II.11,

II.12, II.14, II.16,

II.17, II.23, II.25,

II.27, II.28, II.29,

II.30, II.31, II.32,

II.33, II.34, II.35

3.5, 3.10 III.10, III.11, III.13,

III.14, III.25, III.26,

III.27, III.30

4.9, 4.10, 4.11, 4.14 IV.11, IV.13, IV.15,

IV.16, IV.17, IV.25

5.2, 5.5, 5.8, 5.10 V.4, V.5, V.9, V.12,

V.14

PP 907 Clinical

Pharmacokinetics 2 1

1.5, 1.7, 1.8, I.9,

1.10

I.12, I.18, I.20, I.21,

I.22, I.23, I.24, I.25,

I.27, I.28

2.8, 2.17 II.16, II.17, II.40

3.1, 3.9, 3.10 III.1, III.24, III.28

4.10, 4.13, 4.14 IV.15, IV.20, IV.22,

IV.23

5.1, 5.3, 5.4, 5.6,

5.8, 5.9. 5.10

V.1, V.6, V.7, V.10,

V.12, V.13, V.14

PP 908 Oncology 2 1

1.4, 1.5, 1.8, 1.9,

1.10

I.8, I.9, I.10, I.11,

I.12, I.13, I.21, I.22,

I.23, I.24, I.27, I.28.


62

2.1, 2.5, 2.8, 2.9,

2.11, 2.12, 2.13,

2.20

II.3, II.11, II.12,

II.16, II.17, II.19,

II.20, II.24, II.25,

II.28, II.29, II.30,

II.31, II.32, II.33,

II.34, II.44

3.1, 3.2, 3.5, 3.10,

3.12


III.11, III.13, III.14,

III.25, III.26, III.28,

III.30, III.33

4.9, 4.10, 4.11,

4.13, 4.14

IV.11, IV.12, IV.15,

IV.16, IV.17, IV.20,

IV.25

5.2, 5.3, 5.5, 5.8,

5.10

V.4, V.5, V.6, V.9,

V.12, V.14

PP 909 Clinical Nutrition 1 1

1.4, 1.5, 1.6, 1.7,

1.8, 1.10

I.9, I.10, I.11, I.12,

I.13, I.14, I.16, I.17,

I.19, I.21, I.22, I.24,

I.27, I.28

2.1, 2.11, 2.12,

2.13, 2.15

II.3, II.23, II.25,

II.26, II.27, II.29,

II.30, II.31, II.34,

II.36

3.1, 3.5, 3.10 III.1, III.10, III.12,

III.30

4.9, 4.10, 4.14 IV.14, IV.16, IV.22,

IV.23, IV.25

5.1, 5.2, 5.3, 5.4,

5.5, 5.8, 5.9, 5.10

V.1, V.2, V.4, V.5,

V.6, V.7, V.8, V.9,

V.12, V.13, V.14

PO 906 Clinical Pharmacology 2 1

1.4, 1.5, 1.8, 1.10 I.7, I.8, I.9, I.11,

I.12, I.22, I.23, I.24,

I.27

2.1, 2.5, 2.8, 2.11,

2.12, 2.13, 2.14

II.3, II.11, II.12,

II.16, II.17, II.23,

II.25, II.27, II.28,

II.30, II.31, II.32,

II.33, II.34, II.35

3.5, 3.10 III.10, III.11, III.25,

III.26, III.27

4.9, 4.10, 4.11 IV.11, IV.15, IV.17

5.2, 5.8 V.4, V.5, V.12

HU 903 Sociology 1 - 1.8, 1.9, 1.10 I.21, I.25, I.26, I.27

2.1, 2.21 II.4, II.46


63

3.5, 3.10 III.13, III.29

--- -----

5.1 V.1, V.3

PME5 Biological

Standardization 2 -

1.3, 1.7, 1.8 I.5, I.18, I.23

2.4, 2.8, 2.17 II.8, II.9, II.17, II.40

3.4 III.7, III.9

4.3, 4.5 IV.3, IV.4, IV.6,

IV.7

5.4 V.7

PCE11 Drug Design 2 -

1.7, 1.8 I.18, I.19, I.22, I.24

2.5 II.10

-------- ----------

4.6 IV.8

5.1, 5.3, 5.4, 5.8,

5.9

V.1, V.2, V.6, V.8,

V.12, V.13


64

- Semester Ten

Course

Code Course Title

No of


Lect. Pract.

PO 007 Therapeutics-2 2 1

1.4, 1.5, 1.7, 1.8,

1.10

I.7, I.8, I.9, I.11, I.12,

I.13, I.20, I.22, I.23, I.24,

I.27, I.28

2.1, 2.5, 2.6, 2.8,

2.11, 2.12, 2.13,

2.14

II.3, II.10, II.11, II.12,

II.14, II.16, II.17, II.23,

II.25, II.27, II.28, II.29,

II.30, II.31, II.32, II.33,

II.34, II.35

3.5, 3.10 III.10, III.11, III.13,

III.14, III.25, III.26,

III.27, III.30

4.9, 4.10, 4.11 IV.11, IV.13, IV.15,

IV.16, IV.17

5.2, 5.5, 5.8, 5.10 V.4, V.5, V.9, V.12, V.14

PP 010

Treatment of

Dermatological &

Reproductive

Diseases

1 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11,

I.12, I.13, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28

2.12, 2.13 II.27, II.28, II.30, II.31,

II.32

3.1, 3.5, 3.9, 3.10 III.1, III.10, III.11, III.13,


4.9, 4.11, 4.13, 4.14 IV.11, IV.13, IV.14,

IV.17, IV.20, IV.22

5.1, 5.3, 5.6, 5.8,

5.9, 5.10

V.1, V.6, V.10, V.12,

V.13, V.14

PP 011 Treatment of Pediatric Diseases 2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11,

I.12, I.13, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28

2.12, 2.13 II.27, II.28, II.31, II.32

3.1, 3.5, 3.9, 3.10 III.1, III.10, III.11, III.13,


4.9, 4.10, 4.11,

4.13, 4.14

IV.11, IV.13, IV.14,

IV.15, IV.17, IV.20,

IV.22

5.1, 5.3, 5.6, 5.8,

5.9, 5.10

V.1, V.6, V.10, V.12,

V.13, V.14

PP 012 Treatment of Cardiovascular Diseases

2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11,

I.12, I.13, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28


65

2.12, 2.13 II.27, II.28, II.30, II.32

3.1, 3.5, 3.9, 3.10 III.1, III.10, III.11, III.13,


4.9, 4.11, 4.13, 4.14 IV.11, IV.13, IV.14,

IV.17, IV.20, IV.22

5.1, 5.3, 5.6, 5.8,

5.9, 5.10

V.1, V.6, V.10, V.12,

V.13, V.14

PP 013 Gastroenterology 2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11,

I.12, I.13, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28

2.12, 2.13 II.27, II.28, II.30, II.32

3.1, 3.5, 3.9, 3.10 III.1, III.10, III.11, III.13,


4.9, 4.11, 4.13, 4.14 IV.11, IV.13, IV.14,

IV.17, IV.20, IV.22

5.1, 5.3, 5.6, 5.8,

5.9, 5.10

V.1, V.6, V.10, V.12,

V.13, V.14

PP 014 Treatment of Respiratory System Diseases

2 1

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.9, I.10, I.11,

I.12, I.13, I.20, I.21, I.22,

I.23, I.24, I.25, I.27, I.28

2.9, 2.12, 2.13 II.19, II.27, II.28, II.30,

II.31, II.32

3.1, 3.5, 3.9, 3.10 III.1, III.10, III.11, III.13,


4.9, 4.10, 4.11,

4.13, 4.14

IV.11, IV.13, IV.14,

IV.15, IV.17, IV.20,

IV.22

5.1, 5.3, 5.6, 5.8,

5.10

V.1, V.3, V.6, V.10,

V.12, V.14

PP 015 Drug Information 1 -

1.4, 1.5, 1.7, 1.8,

1.9, 1.10

I.7, I.8, I.12, I.13, I.18,

I.19, I.20, I.22, I.23, I.25,

I.28

2.17 II.40

3.1, 3.10, 3.11 III.1, III.27, III.31

4.12, 4.13 IV.18, IV.19, IV.21

5.1, 5.2, 5.4, 5.6,

5.8, 5.10

V.1, V.4, V.5, V.7, V.8,

V.10, V.12, V.14


66

Summer Training: (graduation requirement) (300 hour)

Every student should complete at least 200 hours (100 credit hours) of training in pharmacy

settings such as community pharmacies, hospital pharmacies, pharmaceutical firms or

research institutes and universities. A further 100 credit hours of clinical training in a

teaching hospital are required. Students commence their training during the summer vacation

preceding the 3rd

, 4th

or 5th

year of study.

Table (4): Summer Training

Graduation Requirement NARS Programme ILOs

- Not less than 200 hours

during the summer vacation

preceding the 3rd

, 4th

, or 5th

year of study in any

pharmaceutical

establishment

- Not less than 100 hours

during the summer vacation

preceding the, 4th

, or 5th

year

of study in a hospital

- 1.1, 1.2, 1.3, 1.4, 1.5,

1.6, 1.7, 1.8, 1.9, 1.10

- I.1, I.2, I.3, I.4, I.5, I.6, I.7, I.8, I.9,

I.10, I.11, I.12, I.13, I.16, I.17, I.18,

I.19, I.20, I.21, I.22, I.23, I.24, I.25,

I.27, I.28

- 2.1, 2.3, 2.5, 2.6, 2.9,

2.11, 2.12, 2.13, 2.14,

2.15, 2.16, 2.18, 2.19,

2.20, 2.21

- II.3, II.7, II.12, II.13, II.14, II.18, II.19,

II.20, II.23, II.25, II.26, II.27, II.28,

II.29, II.30, II.31, II.32, II.33, II.35,

11.36, II.38, II.41, II.42, II.43, II.44,

II.45

- 3.1, 3.2, 3.3, 3.5, 3.8,

3.9, 3.10, 3.12

- III.1, III.2, III.3, III.4, III.10, III.11,

III.12, III.13, III.14, III.22, III.23,

III.24, III.25, III.26, III.27, III.28,


- 4.2, 4.3, 4.4, 4.8, 4.9,

4.10, 4.13, 4.14

- IV.2, IV.3, IV.5, IV.10, IV.12, IV.13,

IV.16, IV.20, IV.24, IV.25

- 5.1, 5.2, 5.3, 5.4, 5.5,

5.6, 5.7, 5.8, 5.9, 5.10

- V.1, V.2, V.3, V.4, V.5, V.6, V.7, V.8,

V.9, V.10, V.11, V.12, V.13, IV.14

Table (5): ICDL

Graduation requirement

NARS Programme ILOs

ICDL

- 1.7, 1.8 - I.18, I.19, I.22

- 2.1, 2.19, 2.20 - II.2, II.42, II.43, II.44

- 3.11 - III.31

- 4.13 - IV.19, IV.21

- 5.1, 5.2,5.4, 5.5, 5.8, 5.9 - V.1, V.2, V.4, V.5, V.7, V.8, V.9,

V.12, V.13


67

4. Curriculum structure and contents

The following table showing the undergraduate programme core curriculum

Table (6): Comparison between curriculum structures of the programme vs. NARS

Sciences Courses Credit

Hours

Total

Hours

Percentage

(NARS)

Basic Physical & Inorganic Chemistry 3 27 14.52%

(10-15%)

Pharmaceutical Chemistry-I 3

Biophysics 2

Botany & Medicinal Plants 3

Cell Biology 2

Mathematics & Statistics 2

Pharmaceutical Organic Chemistry-II 3

Pharmaceutical Analytical Chemistry-I 3

Pharmaceutical Organic Chemistry-III 3

Pharmaceutical Analytical Chemistry-II 3

Pharmaceutical Pharmacognosy-I 3 54 29.03%

(35-40%)

Physical Pharmacy 3

Pharmacy Orientation 2

Pharmacognosy-II 3

Medical Terminology 2

Phytochemistry-I 3

Instrumental Analysis 2

Pharmaceutical Dosage Forms-I 3

Medicinal Chemistry-I 3

Pharmaceutical Dosage Forms-II 3

Phytochemistry-II 3

Medicinal Chemistry-II 3

Pharmaceutical Technology 3

Biopharmaceutics & Pharmacokinetics. 3

Quality Control of Herbal Drugs 3

Radiopharmaceuticals 1

Controlled Drug Delivery System 2

Pharmaceutical Biotechnology 3

Pharmaceutical Microbiology 3

Pharmaceutical Analysis & Quality

Control

3

Medical Histology 3 49 26.34%

(20-25%)

Anatomy 2

Physiology 4

Biochemistry-I 3

General Microbiology & Immunology 4

Parasitology 2

Clinical Microbiology 3

Biochemistry-II 3


68

Pathophysiology 2

Pathology 3

Pharmacology-I 3

Pharmacology-II 3

Clinical Biochemistry 3

Therapeutics-I 3

Clinical Nutrition 2

Clinical Pharmacology 3

Therapeutics-II 3

Pharmacy

Practice

Pharmacy Legislation 1 39 20.97%

(10-15%)

Community Pharmacy Practice 3

Clinical Pharmacy-I 3

Hospital Pharmacy 3

Clinical Pharmacy-II 3

Phytotherapy 3

Drug Interactions 2

Clinical Pharmacokinetics 3

Oncology 3

Treatment of Cardiovascular Diseases 3

Treatment of Dermatological &

Reproductive Diseases

2

Treatment of Pediatric Diseases 3

Gastroenterology 3

Treatment of Respiratory System Diseases 3

Drug Information 1

Health &

Environmental

Traumas & First Aid 2 7 3.76%

(5-10%) Public Health & Preventive Medicine 2

Toxicology & Forensic Medicine

3

Behavioral

and Social

Sociology 1 3 1.61%

(2-4%) Psychology 2

Pharmacy

Management

Pharmacy Administration 2 3 1.61%

(2-4%) Drug Marketing 1

Discretionary Human Rights 2 4 2.15%

(up to 8%) English Language 2


69

5. Methods and Regulation for programme applicants 'assessment

Student’s performance is assessed by both coursework and examinations. Exams are held at

the end of each course. Methods of assessment include written, oral and practical

examinations, research papers, course assignments and practical work.

Method of assessment Intended learning outcomes

(ILOs)

1 Written examination Knowledge and understanding

Intellectual

2 Practical examination Knowledge and understanding

Intellectual

Professional and practical

3 Oral examination Knowledge and understanding

Intellectual

General and transferable

4 Others (posters, field visit, presentation, projects ..etc. Intellectual

General and transferable

Grading Scheme

Grade Expression Grade Scale Grade Point

Average (GPA)

Numerical Scale

Marks

Excellent A 4 ≥ 90%

A- 3.7 85 - <90%

Very Good B+ 3.3 80 - < 85%

B 3 75 - < 80%

B- 2.7 72.5 - < 75%

Good C+ 2.3 70 - < 72.5%

C 2 67.5 - <70%

C- 1.7 65 - < 67.5%

Fair D+ 1.3 62.5 - < 65%

D 1 60 - < 62.5%

Fail F 0 < 60%

Programme Evaluation:

The Evaluator Tool Samples

1 Senior students Questionnaire, brain storming 10-15%

2 Alumni Questionnaire -

3 Stakeholders Questionnaire 10/year

4 External evaluator for programme &

courses

Site visit, document examination 100%

5i Internal audit Site visit, document examination 100%

5ii Internal evaluators for courses Document examination 90%


70

6. Programme admission requirements

The Faculty of Pharmacy, Cairo University complies with the admission

regulations and requirements of the Egyptian Supreme Council of Universities

(ESCU).

General secondary school certificate with major in biology and chemistry, or an

equivalent certificate from a foreign institute recognized by the university allowed

to apply for the course.

Courses completed at another faculty are evaluated for equivalency to the Faculty

of Pharmacy, Cairo University courses.

a. Transfer Admission Requirement

Transfer students must fulfill the Faculty of Pharmacy admission requirement.

Courses completed at another faculty are evaluated for equivalency to the Faculty

of Pharmacy, Cairo University courses.

The faculty from which the student is to be transferred should be accredited.

b. Courses Registration

Academic advisors are available to help students select the required and suitable

courses from the list of the offered courses. Selection of the courses for any given year

is conditional on the successful completion of the prerequisite course of the preceding

academic year.

c. Courses Load

The course load is the number of registered credit hours per student each semester.

The academic load in each semester ranges from 12-22 credit hours.

The academic load in the summer semester ranges from 4 to 10 credit hours.

Credits acquired by the student are those of passed courses from the registered

academic load.

d. Add, Drop and Withdrawal

Students are allowed to add or drop a course or more during specified time every semester.

Students are allowed to withdraw from a course prior to specified deadline set by the

University. The course will carry a grade “W” and students will be allowed to retake the


71

course when available. Students who withdraw after the deadline will not be allowed to sit for

the relevant exam and will carry grade “F” for that course.

e. Attendance

Students are expected to attend the university on a full-time basis during each semester.

Attendance is checked during seminars, tutorials and labs. Students must attend at least 70%

of the tutorials and practical labs to be allowed to submit the final exams. If absence in a

course exceeded the allowed percentage (25%) during the first two weeks of the semester

(either excused or unexcused), the student will not be allowed to sit for the exam of the

relevant subject and will carry grade “F”.

Programme coordinator:

Name: Prof. Dr. Manal Maher

Signature: …………………………………………………………………………………

Date: / /2010

Programme Specifications Bachelor of Pharmaceutical ... · Department of Microbiology and...

Documents

Transcript of Programme Specifications Bachelor of Pharmaceutical ... · Department of Microbiology and...